Aditxt - ADTX Stock Forecast, Price & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aditxt in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ADTX shares.
View ADTX analyst ratings or view top-rated stocks.

2 Wall Street research analysts have issued 12-month price targets for Aditxt's stock. Their ADTX share price forecasts range from $4.00 to $4.00. On average, they predict the company's share price to reach $4.00 in the next year. This suggests a possible upside of 344.4% from the stock's current price.
View analysts price targets for ADTX or view top-rated stocks among Wall Street analysts.

Aditxt's stock was trading at $1.1546 at the beginning of the year. Since then, ADTX shares have decreased by 22.1% and is now trading at $0.90.
View the best growth stocks for 2023 here.

Aditxt saw a increase in short interest in February. As of February 28th, there was short interest totaling 111,500 shares, an increase of 29.2% from the February 13th total of 86,300 shares. Based on an average trading volume of 164,300 shares, the days-to-cover ratio is currently 0.7 days. Currently, 2.6% of the shares of the stock are short sold.
View Aditxt's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, March 20th 2023.
View our ADTX earnings forecast.

Aditxt, Inc. (NASDAQ:ADTX) announced its quarterly earnings data on Wednesday, August, 11th. The company reported ($21.00) EPS for the quarter, missing the consensus estimate of ($2.50) by $18.50. Aditxt had a negative trailing twelve-month return on equity of 601.11% and a negative net margin of 5,101.67%.

Shares of Aditxt reverse split on the morning of Wednesday, September 14th 2022. The 1-50 reverse split was announced on Wednesday, September 14th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, September 14th 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aditxt investors own include Tesla (TSLA), Dynavax Technologies (DVAX), Boeing (BA), CrowdStrike (CRWD), Genius Brands International (GNUS), Nikola (NKLA), Block (SQ), Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV) and Arbutus Biopharma (ABUS).

Aditxt trades on the NASDAQ under the ticker symbol "ADTX."

Aditxt's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Amro A Albanna, Corinne Pankovcin, Shahrokh Shabahang and Thomas J Farley.
View institutional ownership trends.

Shares of ADTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ADTX stock can currently be purchased for approximately $0.90.

Aditxt (NASDAQ:ADTX) has a market capitalization of $3.74 million and generates $110,000.00 in revenue each year.

Aditxt's mailing address is 2569 WYANDOTTE ST. SUITE 101, MOUNTAIN CA, 94043. The official website for the company is www.aditxt.com. The company can be reached via email at ir@aditxt.com.